… Patients were randomly assigned to receive raloxifene 60 mg/d, raloxifene 120 mg/d, or
placebo. All reported breast cancers were confirmed by pathology report, and, whenever …

… All women received 500 mg/day calcium supplementation and 400– 600 IU of vitamin D.
The sponsor supplied randomly numbered kits containing identically appearing raloxifene and …

Optimal coverage of prandial insulin requirements remains an elusive goal. The invention of
rapid-acting insulin analogs (RAIAs) was a big step forward in reducing postprandial …

Publisher Summary This chapter discusses the methods of biosynthetic enrichment of
proteins with 15 N in backbone and side-chain groups, as exemplified by the work with …

… D, Fourteen volunteers received 0.15 U/kg, with the following results: AUC 0 60 291%, C
210%, T -26 minutes, and AUC > 2h 53%; G 1h 232%, G 2h 161%, onset of action -16 minutes, …

… assay was used to screen for reduced lysozyme production at increasing growth
temperatures (D. C. Muchmore, unpublished results; Alber & Matthews, 1987). Cloning and DNA …

OBJECTIVE To compare the efficacy and safety of two daily doses of the new sulfonylurea,
glimepiride (Amaryl), each as a once-daily dose or in two divided doses, in patients with …

… Newman W, Laqua D, Engelbrecht D, Impact of glucose selfmonitoring on glycohemoglobin
values in a veteran population. Arch Int Med 150:107-110, 1990 7. Allen B, DeLong E, …

Raloxifene HCl, a selective estrogen receptor modulator, has been shown to increase bone
mineral density (BMD) and decrease biochemical markers of bone turnover in …

We recently reported2 that the lithium-amine reduction of enol diethyl phosphates prepared
by phos-phorylation ofenolate anions was an efficient method for the regiospecific formation …